<it>Ex vivo </it>susceptibility of <it>Plasmodium falciparum </it>isolates from Dakar, Senegal, to seven standard anti-malarial drugs
Pradines Bruno, Wade Boubacar, Bercion Raymond and 10 more
Malaria Journal · 2011
doi:10.1186/1475-2875-10-310 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
<p>Abstract</p> <p>Background</p> <p>As a result of widespread chloroquine and sulphadoxine-pyrimethamine resistance, artemisinin-based combination therapy (ACT) (which includes artemether-lumefantrine and artesunate-amodiaquine) has been recommended as a first-line anti-malarial regimen in Senegal since 2006. Since then, there have been very few reports on the <it>ex vivo </it>susceptibility of <it>Plasmodium falciparum </it>to anti-malarial drugs. To examine whether parasite susceptibility has been affected by the widespread use of ACT, the <it>ex vivo </it>susceptibility of local isolates was assessed at the military hospital of Dakar.</p> <p>Methods</p> <p>The <it>ex vivo </it>susceptibility of 93 <it>P. falciparum </it>isolates from Dakar was successfully determined using the <it>Plasmodium </it>lactate dehydrogenase (pLDH) ELISA for the following drugs: chloroquine (CQ), quinine (QN), mefloquine (MQ), monodesethylamodiaquine (MDAQ), lumefantrine (LMF), dihydroartemisinin (DHA) and doxycycline (DOX).</p> <p>Results</p> <p>After transformation of the isolate IC<sub>50 </sub>in ratio of IC<sub>50 </sub>according to the susceptibility of the 3D7 reference strain (isolate IC<sub>50</sub>/3D7 IC<sub>50</sub>), the prevalence of the <it>in vitro </it>resistant isolates with reduced susceptibility was 50% for MQ, 22% for CQ, 12% for DOX, 6% for both QN and MDAQ and 1% for the drugs LMF and DHA. The highest significant positive correlations were shown between responses to CQ and MDAQ (<it>r </it>= 0.569; <it>P </it>< 0.0001), LMF and QN (<it>r </it>= 0.511; <it>P </it>< 0.0001), LMF and DHA (<it>r </it>= 0.428; <it>P </it>= 0.0001), LMF and MQ (<it>r </it>= 0.413; <it>P </it>= 0.0002), QN and DHA (<it>r </it>= 0.402; <it>P </it>= 0.0003) and QN and MQ (<it>r </it>= 0.421; <it>P </it>= 0.0001).</p> <p>Conclusions</p> <p>The introduction of ACT in 2002 has not induced a decrease in <it>P. falciparum </it>susceptibility to the drugs DHA, MDAQ and LMF, which are common ACT components. However, the prevalence of <it>P. falciparum </it>isolates with reduced susceptibility has increased for both MQ and DOX. Taken together, these data suggest that intensive surveillance of the <it>P. falciparum in vitro </it>susceptibility to anti-malarial drugs in Senegal is required.</p>
Abstract licence: CC BY-NC-ND
Cited by papers we hold1
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.